Heshouwu (Polygonum Multiflorum Thunb.) Ethanol Extract Suppresses Pre-adipocytes Differentiation in 3T3-L1 Cells and Adiposity in Obese Mice
Overview
General Medicine
Pharmacology
Affiliations
This study investigated whether Heshouwu (Polygonum multiflorum Thunb.) root ethanol extract (PME) has anti-obesity activity using 3T3-L1 cells and high-fat diet (HFD)-induced obese mice. Treatment with PME (5 and 10 μg/mL) dose-dependently suppressed 3T3-L1 pre-adipocyte differentiation to adipocytes and cellular triglyceride contents. In addition, PME inhibited mRNA and protein expression of adipogenic transcription factors such as CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ), which led to down-regulation of fatty acid synthase gene expression. After feeding mice PME (0.05%) with HFD for 12 weeks, their visceral fat mass, size and body weight were significantly reduced compared with the HFD group. Furthermore, PME supplementation significantly up-regulated the PPARα, CPT1, CPT2, UCP1 and HSL mRNA levels compared with the HFD group, whereas it down-regulated expression of the PPARγ and DGAT2 genes. Finally, HFD increased serum leptin, insulin, glucose and insulin and glucose levels; however, PME reversed these changes. These results demonstrated that PME might relieve obesity that occurs via inhibition of adipogenesis and lipogenesis as well as through lipolysis and fatty acid oxidation in 3T3-L1 cells and HFD-induced obese mice.
Deciphering Mechanisms of Adipocyte Differentiation in Abdominal Fat of Broilers.
Sun X, Liu X, Wang C, Ren Z, Yang X, Liu Y J Agric Food Chem. 2024; 72(45):25403-25413.
PMID: 39483088 PMC: 11565640. DOI: 10.1021/acs.jafc.4c06867.
Gao H, Yang J, Wang X, Song Y, Cheng X, Wei F Molecules. 2022; 27(19).
PMID: 36235293 PMC: 9570674. DOI: 10.3390/molecules27196760.
Choi R, Lee M Plants (Basel). 2021; 10(8).
PMID: 34451554 PMC: 8398201. DOI: 10.3390/plants10081509.
The Anti-Obesity Effect of Traditional Chinese Medicine on Lipid Metabolism.
Fan Q, Xu F, Liang B, Zou X Front Pharmacol. 2021; 12:696603.
PMID: 34234682 PMC: 8255923. DOI: 10.3389/fphar.2021.696603.
Kim D, Kim H, Jun H Evid Based Complement Alternat Med. 2020; 2020:7642019.
PMID: 32714420 PMC: 7334760. DOI: 10.1155/2020/7642019.